Form 8-K - Current report:
SEC Accession No. 0001628280-25-032099
Filing Date
2025-06-18
Accepted
2025-06-18 16:04:23
Documents
13
Period of Report
2025-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K zlab-20250618.htm   iXBRL 8-K 97209
  Complete submission text file 0001628280-25-032099.txt   257112

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20250618.xsd EX-101.SCH 2151
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zlab-20250618_def.xml EX-101.DEF 15888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zlab-20250618_lab.xml EX-101.LAB 27758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zlab-20250618_pre.xml EX-101.PRE 16626
15 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20250618_htm.xml XML 4062
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 251056834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)